ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer.

ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer. Clin Cancer Res. 2021 03 15; 27(6):1663-1670.

View in: PubMed

subject areas

B7-H1 Antigen
Biomarkers, Tumor
Colorectal Neoplasms
CTLA-4 Antigen
DNA-Binding Proteins
Follow-Up Studies
Gene Expression Profiling
Humans
Microsatellite Instability
Mutation
Prognosis
Programmed Cell Death 1 Receptor
Retrospective Studies
T-Lymphocytes, Cytotoxic
Transcription Factors

authors with profiles

JAFFER A AJANI
DIPEN MAHESHBHAI MARU
MICHAEL JAMES OVERMAN